Mirum Pharmaceuticals, Inc. MIRM Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets?
- Mirum Pharmaceuticals, Inc. (MIRM) reported operating lease right-of-use assets in other assets of $12.65M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets increased by 65.0% year-over-year, from $7.66M to $12.65M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets has grown at a 35.0% compound annual growth rate (CAGR), from $1.95M to $8.74M.